{"date":"2025-11-18","count":7,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7827-2025-11-18-1750-bz1qwa","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-11-18","time":"17:50:49","subject":"因應本公司創新板上市申請需求，委託會計師出具內部控制制度審查確信報告","clause":"第25款","fact_date":"2025-11-18","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-11-18 17:50，「因應本公司創新板上市申請需求，委託會計師出具內部控制制度審查確信報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-11-18-1633-hv34e8","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-11-18","time":"16:33:44","subject":"本公司決議召開115年第一次股東臨時會相關事宜","clause":"第32款","fact_date":"2025-11-18","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-11-18 16:33，「本公司決議召開115年第一次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-11-18-1539-100esni","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-11-18","time":"15:39:23","subject":"公告本公司研發主管異動","clause":"第11款","fact_date":"2025-11-18","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-11-18 15:39，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-11-18-1530-fz6eki","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-11-18","time":"15:30:37","subject":"公告本公司董事長訂定114年上半年度現金股利除息基準日相關事宜","clause":"第14款","fact_date":"2025-11-18","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-11-18 15:30，「公告本公司董事長訂定114年上半年度現金股利除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2025-11-18-1507-1wbt819","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2025-11-18","time":"15:07:29","subject":"本公司受邀參加台新證券舉辦之投資論壇","clause":"第12款","fact_date":"2025-11-26","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2025-11-18 15:07，「本公司受邀參加台新證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2025-11-18-0955-10yb8rh","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2025-11-18","time":"09:55:02","subject":"本公司受邀參加元富證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-11-19","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2025-11-18 09:55，「本公司受邀參加元富證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-11-18-0650-1hxusdh","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-11-18","time":"06:50:12","subject":"代美國子公司Tulex Pharmaceuticals(以下簡稱Tulex)公告與合作夥伴共同開發之TLX-032治療自閉症新藥於2a期臨床試驗中取得正面結果","clause":"第53款","fact_date":"2025-11-18","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-11-18 06:50，「代美國子公司Tulex Pharmaceuticals(以下簡稱Tulex)公告與合作夥伴共同開發之TLX-032治療自」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}